NOTES
TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
FOR
THE THREE MONTHS ENDED MARCH 31, 2020 AND 2019 (UNAUDITED)
(Currency
expressed in United States Dollars (“US$”), except for number of shares)
The
accompanying unaudited condensed consolidated financial statements have been prepared by management in accordance with both accounting
principles generally accepted in the United States (“GAAP”), and the instructions to Form 10-Q and Rule 10-01 of Regulation
S-X. Certain information and note disclosures normally included in audited financial statements prepared in accordance with generally
accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes
that the disclosures made are adequate to make the information not misleading.
In
the opinion of management, the balance sheet as of March 31, 2020 which has been derived from unaudited financial statements and
these unaudited condensed consolidated financial statements reflect all normal and recurring adjustments considered necessary
to state fairly the results for the periods presented. The results for the period ended March 31, 2020 are not necessarily indicative
of the results to be expected for the entire fiscal year ending December 31, 2020 or for any future period.
These
unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Management’s
Discussion and the audited financial statements and notes thereto included in the Form 10-K for the year ended December 31, 2019.
2.
|
DESCRIPTION
OF BUSINESS AND ORGANIZATION
|
United
Royale Holdings Corp., formerly known as Bosy Holdings Corp. (“the Company”, “we”, “us” or
“our”) was incorporated in the State of Nevada on June 23, 2015. We intend to offer planting and cultivation services
to land owners in regards to the planting and cultivation of Aquilaria Subintegra & Aquilaria Sinensis trees. We also intend
to provide services relating to the extraction of Agarwood from such trees through a process known as “inoculation.”
On
September 30, 2018, the Company and Mr. CHEN Zheru, representing the sole shareholder of IV Enterprises Development Limited, a
Seychelles corporation (“IVED”), entered into a Sale and Purchase Agreement, pursuant to which the Company acquired
100% (one hundred percent) of the shareholding of IVED. IVED provides tree nurseries, including planting, cultivation and inoculation
services through its wholly-owned subsidiary, Oudh Tech Sdn Bhd, in Malaysia. The acquisition is completed on September 30, 2018.
Mr.
CHEN Zheru is the common director and major shareholder of the Company and IVED. As a result of this common ownership and in accordance
with the FASB Accounting Standards Codification Section 805 “Business Combination”, the transaction is being
treated as a combination between entities under common control. The recognized assets and liabilities were transferred at their
carrying amounts at the date of the transaction. The equity accounts of the combining entities are combined. Further, the companies
will be combined retrospectively for prior year comparative information as if the transaction had occurred on January 1, 2017.
3.
|
SUMMARY
OF SIGNIFICANT ACCOUNTING POLICIES
|
Basis
of presentation
The
accompanying financial statements are prepared in accordance with generally accepted accounting principles in the United States
of America (“US GAAP”).
The
accompanying financial statements include the accounts of the Company and its wholly-owned subsidiaries. Intercompany transactions
and balances were eliminated in consolidation.
Below
is the organization chart of the Group.
Use
of estimates
Management
uses estimates and assumptions in preparing these financial statements in accordance with US GAAP. Those estimates and assumptions
affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities in the balance sheet,
and the reported revenue and expenses during the periods reported. Actual results may differ from these estimates.
Going
Concern
The
accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and
the settlement of liabilities and commitments in the normal course of business. During the three months ended March 31, 2020,
the Company incurred a net loss of $48,357 and used cash in operations of $59,027. These factors raise substantial doubt about
the Company’s ability to continue as a going concern within one year of the date that the financial statements are issued.
In addition, the Company’s independent registered public accounting firm, in its report on the Company’s December
31, 2019 financial statements, has expressed substantial doubt about the Company’s ability to continue as a going concern.
The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going
concern.
The
Company’s ability to continue as a going concern is dependent upon improving its profitability and the continuing financial
support from its shareholders. Management believes the existing shareholders or external financing will provide the additional
cash to meet the Company’s obligations as they become due. Despite the amount of funds that we have raised, no assurance
can be given that any future financing, if needed, will be available or, if available, that it will be on terms that are satisfactory
to the Company. Even if the Company is able to obtain additional financing, if needed, it may contain undue restrictions on its
operations, in the case of debt financing, or cause substantial dilution for its stockholders, in the case of equity financing.
Cash
and cash equivalents
Cash
and cash equivalents are carried at cost and represent cash on hand, demand deposits placed with banks or other financial institutions
and all highly liquid investments with an original maturity of three months or less as of the purchase date of such investments.
Our
deposit in Hong Kong is currently deposit in HSBC Hong Kong, and there is a Deposit Protection Scheme protects our eligible deposits
held with bank in Hong Kong which is members of the Scheme. The scheme will pay us a compensation up to a limit of HKD500,000,
which is equivalent to $64,102, if HSBC Hong Kong fails.
Our
deposit in Malaysia is currently deposit in Malayan Banking Berhad, and there is a Perbadanan Insurans Deposit Malaysia protects
our eligible deposits held with bank in Malaysia which is members of the Scheme. The scheme will pay a compensation up to a limit
of Malaysia Ringgit (“MYR”) 250,000 per deposit per member bank, which is equivalent to $61,234, if the aforementioned
banks fails.
Plant
and equipment
Plant
and equipment are stated at cost less accumulated depreciation and impairment. Depreciation of plant, equipment and software are
calculated on the straight-line method over their estimated useful lives or lease terms generally as follows:
Classification
|
|
Useful
Life
|
Computer
and Software
|
|
3
years
|
Equipment
|
|
10
years
|
The
Company purchased 2 computers at the end of June 2017, and the computers has been subject to depreciation since the utilization
in July 2017. Expenditures for maintenance and repairs will be expensed as incurred.
Biological
Assets
Biological
Assets of the Company comprise of agarwood sapling and plantation cost of agarwood.
Pursuant
to ASC 905-360-25-2, biological Assets are planted and brought to production by the Company or on a contract basis. Saplings are
usually purchased as nursery stock and transplanted into the farmland in the desired pattern. Cost of biological assets consists
of accumulated planation development costs incurred from commencement of planting of seedlings up to maturity of the crop cultivated.
Capitalization of planation development and other operating costs ceases upon commencement of commercial harvesting, which range
from 7 to 9 years. Net proceeds from sales of products before commercial production begins shall be applied to the capitalized
cost of the plants, trees, or vines.
Biological
Assets is measured using average cost, and is measured at the lower of cost and net realizable value. When evidence exists that
the net realizable value of biological Assets is lower than its cost, the difference shall be recognized as a loss in earnings
in the period in which it occurs. Impairment loss may be required, for example, due to damage, physical deterioration, obsolescence,
changes in price levels, or other causes.
Pursuant
to ASC 905-360-35-4, when production in commercial quantities begins, the accumulated costs shall be depreciated over the estimated
useful life of the particular farmland.
Foreign
currencies translation
Transactions
denominated in currencies other than the functional currency are translated into the functional currency at the exchange rates
prevailing at the dates of the transaction. Monetary assets and liabilities denominated in currencies other than the functional
currency are translated into the functional currency using the applicable exchange rates at the balance sheet dates. The resulting
exchange differences are recorded in the statement of operations.
The
reporting currency of the Company is the United States Dollars (“US$”) and the accompanying financial statements have
been expressed in US$. Hong Kong Dollars (“HK$”), which is the respective functional currencies for the Company as
the deposit is currently kept in HSBC Hong Kong. In addition, the Company’s subsidiaries maintain their books and records
in their respective local currency, which consists of the Hong Kong Dollars (“HK$”) and Malaysian Ringgit (“MYR”),
which is also the respective functional currency of the subsidiaries.
Translation
of amounts from the local currencies of the Company into US$ has been made at the following exchange rates for the respective
periods:
|
|
As of and for the three months ended
March 31,
|
|
|
|
2020
(Unaudited)
|
|
|
2019
(Unaudited)
|
|
Period-end MYR : US$1 exchange rate
|
|
|
4.31
|
|
|
|
4.08
|
|
Period-average MYR : US$1 exchange rate
|
|
|
4.21
|
|
|
|
4.08
|
|
Period-end / average HK$ : US$1 exchange rate
|
|
|
7.75
|
|
|
|
7.75
|
|
Income
taxes
The
Company accounts for income taxes using the asset and liability method. The asset and liability method requires recognition of
deferred tax assets and liabilities for expected future tax consequences of temporary differences that currently exist between
tax bases and financial reporting bases of the Company’s assets and liabilities. Deferred income tax assets and liabilities
are measured using enacted tax rates expected to apply to taxable income in the years in which these temporary differences are
expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized
in income in the period that includes the enactment date. A valuation allowance is provided on deferred taxes if it is determined
that it is more likely than not that the asset will not be realized. The Company recognizes penalties and interest accrued related
to income tax liabilities in the provision for income taxes in its Consolidated Statements of Income.
Significant
management judgment is required to determine the amount of benefit to be recognized in relation to an uncertain tax position.
The Company uses a two-step process to evaluate tax positions. The first step requires an entity to determine whether it is more
likely than not (greater than 50% chance) that the tax position will be sustained. The second step requires an entity to recognize
in the financial statements the benefit of a tax position that meets the more-likely-than-not recognition criterion. The amounts
ultimately paid upon resolution of issues raised by taxing authorities may differ materially from the amounts accrued and may
materially impact the financial statements of the Company in future periods.
Fair
value of financial instruments
The
carrying value of the Company’s financial instruments: cash and cash equivalents, prepayments, amount due to a director
and accrued liabilities approximate at their fair values because of the short-term nature of these financial instruments.
The
Company follows the guidance of the ASC Topic 820-10, “Fair Value Measurements and Disclosures” (“ASC 820-10”),
with respect to financial assets and liabilities that are measured at fair value. ASC 820-10 establishes a three-tier fair value
hierarchy that prioritizes the inputs used in measuring fair value as follows:
●
Level 1 : Observable inputs such as quoted prices in active markets;
●
Level 2 : Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
●
Level 3 : Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own
assumptions
Lease
Prior
to January 1, 2019, the Company had not entered into formal lease agreement and the Company accounted for leases under ASC 840,
Accounting for Leases. Effective July 1, 2019, the Company adopted the guidance of ASC 842, Leases, which requires an entity to
recognize a right-of-use asset and a lease liability for virtually all leases. The implementation of ASC 842 did not have a material
impact on the Company’s consolidated financial statements and did not have a significant impact on our liquidity or on our
compliance with our financial covenants associated with our loans. The Company adopted ASC 842 using a modified retrospective
approach. As a result, the comparative financial information has not been updated and the required disclosures prior to the date
of adoption have not been updated and continue to be reported under the accounting standards in effect for those periods. The
adoption of ASC 842 on January 1, 2019 resulted in the recognition of operating lease right-of-use assets of $21,330, lease liabilities
for operating leases of $21,330, and a zero cumulative-effect adjustment to accumulated deficit. See Note 8 for further information
regarding the impact of the adoption of ASC 842 on the Company’s financial statements.
Recent
accounting pronouncements
In
November 2016, the FASB issued Accounting Standards Update No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (ASU
2016-18), which requires companies to include amounts generally described as restricted cash and restricted cash equivalents in
cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown on the statement of cash
flows. We adopted the new standard effective January 1, 2018, and the standard did not have a material impact on our financial
statements.
In
January 2017, the FASB issued Accounting Standards Update No. 2017-01, Business Combinations (Topic 805): Clarifying the Definition
of a Business (ASU 2017-01), which revises the definition of a business and provides new guidance in evaluating when a set of
transferred assets and activities is a business. We adopted the new standard effective January 1, 2018 on a prospective basis.
The new standard did not have a material impact on our consolidated financial statements.
The
Company has reviewed all recently issued, but not yet effective, accounting pronouncements and do not believe the future adoption
of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.
The
prepaid expenses as of March 31, 2020 included OTCQB annual fee of $9,000, deposit of $665 in transfer agent, deposit of $6,410
in the consulting service provider and $696 in our farmland provider, while the prepaid expenses as of December 31, 2019 included
OTCQB annual fee of $12,000, deposit of $2,013 and $6,410 in transfer agent and our consultancy firm, and deposit of $734 in our
farmland provider.
5.
|
PLANT
AND EQUIPMENT, NET
|
|
|
As of
March 31, 2020
|
|
|
As of
December 31, 2019
|
|
|
|
|
(Unaudited)
|
|
|
|
|
|
Computer and Software
|
|
$
|
3,878
|
|
|
$
|
3,878
|
|
Equipment
|
|
|
1,816
|
|
|
|
1,816
|
|
|
|
|
5,694
|
|
|
|
5,694
|
|
Less: Accumulated Depreciation
|
|
|
(4,125
|
)
|
|
|
(3,688
|
)
|
Plant and equipment, net
|
|
$
|
1,569
|
|
|
$
|
2,006
|
|
The
Company acquired computers and a software at $3,878 in 2017, and the accumulated depreciations as of March 31, 2020 and December
31, 2019 were $3,555 and $3,232 respectively.
The
Company acquired Engine Pump at $1,816 in 2017. The accumulated depreciations as of March 31, 2020 and December 31, 2019 were
$570 and $456 respectively.
The
depreciation expense for March 31, 2020 and 2019 were $437 and $369 respectively.
Biological
Assets of the Company comprise of agarwood sapling and plantation cost of agarwood.
The
Company acquired the agarwood sapling at MYR98,800 (approximately $23,587) in 2017. The accumulated planation development costs
incurred from commencement of planting of seedlings up to March 31, 2020 and December 31, 2019 were $36,537 and $37,297 respectively.
The reason for difference between two amounts is the exchange rate difference, which MYR depreciated since March 2020.
7.
|
AMOUNT
DUE TO DIRECTOR
|
As
of March 31, 2020, and December 31, 2019, our directors has loaned to the Company $13,848 and $11,284 as working capital, respectively.
This loan is unsecured, non-interest bearing and due on demand. We performed the calculation of imputed interest and believed
the imputed interest is not significant when compare to our balance sheet size and total expense, and as a result, we didn’t
capture this figure into our financial statements.
The
Company has operating lease agreements for a farmland with remaining lease terms of 6 years. The Company does not have any other
leases. The Company accounts for the lease and non-lease components of its leases as a single lease component. Lease expense is
recognized on a straight-line basis over the lease term.
Operating
lease right-of-use (“ROU”) assets and liabilities are recognized at commencement date based on the present value of
lease payments over the lease term. ROU assets represent our right to use an underlying asset for the lease term and lease liabilities
represent our obligation to make lease payments arising from the lease. Generally the implicit rate of interest in arrangements
is not readily determinable and the Company utilizes its incremental borrowing rate in determining the present value of lease
payments. The Company’s incremental borrowing rate is a hypothetical rate based on its understanding of what its credit
rating would be. The operating lease ROU asset includes any lease payments made and excludes lease incentives.
This
standard did not have a significant impact on our liquidity.
The
components of lease expense and supplemental cash flow information related to leases for the period are as follows:
|
|
Three
Months ended March 31, 2020
|
|
|
|
|
(Unaudited)
|
|
Lease
Cost
|
|
|
|
|
Operating
lease cost (included in general and administrative expenses in the Company’s unaudited condensed statement of operations)
|
|
$
|
1,008
|
|
|
|
|
|
|
Other
Information
|
|
|
|
|
Cash
paid for amounts included in the measurement of lease liabilities for the three months ended March 31, 2020
|
|
$
|
1,008
|
|
Remaining
lease term – operating lease (in years)
|
|
|
5
|
|
Discount
rate – operating lease
|
|
|
6.65
|
%
|
|
|
As
of
March 31, 2020
|
|
|
|
|
(Unaudited)
|
|
Operating
lease
|
|
|
|
|
Right-of-use
assets, net
|
|
$
|
17,805
|
|
|
|
|
|
|
Operating
lease liabilities – current portion
|
|
|
3,105
|
|
Operating
lease liabilities – non-current portion
|
|
|
14,700
|
|
Total
operating lease liabilities
|
|
$
|
17,805
|
|
Maturity
of the Company’s lease liabilities are as follows:
Year Ending
|
|
Operating Lease
|
|
2020 (remaining 9 months)
|
|
$
|
3,130
|
|
2021
|
|
|
4,172
|
|
2022
|
|
|
4,172
|
|
2023
|
|
|
4,172
|
|
2024
|
|
|
4,172
|
|
2025 (first 3 months of the fiscal year)
|
|
|
1,044
|
|
Total lease payments
|
|
$
|
20,862
|
|
Less: Present value discount
|
|
|
(3,057
|
)
|
Present value of lease liabilities
|
|
$
|
17,805
|
|
Lease
expenses were $1,008 during the three months ended March 31, 2020 respectively, and there was no rent incurred during the three
months ended March 31, 2019, respectively.
As
of March 31, 2020, and December 31, 2019, there were 141,990,387 and 141,990,387 shares of common stock issued and outstanding
respectively.
There
were no stock options, warrants or other potentially dilutive securities outstanding as of March 31, 2020.
10.
SUBSEQUENT EVENTS
Due
to the Coronavirus outbreak since December, 2019, Malaysia government declared a Movement Control Order from March 18, 2020 to
April 14, 2020. The temporary close down does not have much impact on our current operation, because currently we are in the plantation
progress of Aquilaria Subintegra trees and we expect the harvest will take place within future 4 years’ time. At this moment,
the trees are located at Johor, Malaysia, with sufficient rainfall and sunlight for growing. Once the Movement Control Order is
expired or not extended, we will collaborate with our service provider to performance the maintenance work of the farmland.